Di Nicolantonio, Federica <br/><br/>
Ex vivo characterization of XR11576 (MLN576) against ovarian cancer and other solid tumors.  [electronic resource] 

 -  Anti-cancer drugs  Oct 2004 
 - 849-60 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0959-4973 
<br/><br/><label>Standard No.: </label>10.1097/00001813-200410000-00005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Cell Survival--drug effects<br/>Colorectal Neoplasms--drug therapy<br/>Dose-Response Relationship, Drug<br/>Drug Screening Assays, Antitumor--methods<br/>Female<br/>Humans<br/>Middle Aged<br/>Ovarian Neoplasms--drug therapy<br/>Phenazines--administration & dosage<br/>Statistics, Nonparametric<br/>Tumor Cells, Cultured